RE:RE:RE:RE:RE:RE:RE:RE:RE:This stock will go nowhere, unless one of there other Rabiger1289 wrote: Investor, do you realize the covid revs are going away real soon and big investors realize this, you do know what there Ai revs were in the last earnings report, the market knows it but apparently it escapes you.
Covid money has put a substantial amount of money in the bank and given this company a clean balance sheet which is much better than the majority of stocks on the venture, which by the way many are getting far higher valuations. So if covid revenue were to stop tomorrow, DM has already gotten what it needed from that venture. From this point on covid revenue is all bonus. That money in the bank is backing DM's AI and getting them larger and larger contracts. That money will also add revenue through aquistitions.
At the moment, it seems like covid revenue may be nearing an end, but Screen pro is still signing contracts for testing. We heard this arguement last year when the vaccines came out and yet the testing continued. Even a broken clock is right twice a day. Eventually, you'll be right too. Many countries are seeing another rise in cases and you never know if a new variant pops up that puts everyone back into lockdown. The fact that covid revenue will most likely dwindle doesn't escape any one here. This is not a covid company, but they certainly took advantage of the opportunity. It doesn't escape managment either as they have narrowed down and selected certain verticals to continue to bring in revenue and value for the shareholders long after covid. I think the only person not seeing things is you.
You think big investors don't see what is happening with this company's AI and Medi-Call roll out? I'm a big investor and so is my friend and it sounds like Reeseman is too. We're all still here. Together we probably own 3-4% of this stock. At some point Medi-Call will eventually bring in revenue that may or may not exceed covid revenue over time. Regardless, the revenue will eventually be consistent and predictable and this is extremely important for institutional investment. If you are forward looking, then you can see the potential growth in this company with or without covid revenue. You really are in desperation mode. AI contracts are growing!